Indivior PLC ORD USD0.10

(LSE, Stocks) 
p 270.40 <%= Resources.Global.txtDown %>
Updated 19/09/2018
Change % -0.22% Stock price decreasing
Change -0.60 Stock price decreasing
Volume 2,893,419
High P 272.90
Low P 265.60
Open P 269.70
Prev close P 271.00
# of shares 728.31M
Market cap 196,934M GBX

Market closed
Indivior PLC ORD USD0.10
Market is closed, opens at 08:00
Price development Latest 1 week 1 month 3 months 6 months 1 year
  270.40 0.9% Stock price increasing -0.3% Stock price decreasing -25.8% Stock price decreasing -33.3% Stock price decreasing -14.2% Stock price decreasing
Powered by TradingView

Company profile

Indivior PLC is a specialty and generic drug manufacturing company. The company is focused on the development, manufacture, and sale of prescription drugs based on buprenorphine for treatment of opioid dependence. The vast majority of Indivior's revenue is generated in the United States, followed by the rest of the world. The company considers merger and acquisition investment to be a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

Copyright Berlingske Media 2018  Cookie- and Privacy policy  |  Cookies  |   General terms of trade  |   Terms of use and IP rights
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
20 September 2018 02:34:40
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20180919.1 - EUROWEB1 - 2018-09-20 03:34:40 - 2018-09-20 02:34:40 - 1000 - Website: OKAY